Literature DB >> 7517641

Immunochemical detection of inducible NO synthase in human lung.

W R Tracey1, C Xue, V Klinghofer, J Barlow, J S Pollock, U Förstermann, R A Johns.   

Abstract

Type II (inducible) nitric oxide synthase (NOS) may play an important role in pulmonary pathophysiology, yet it remains controversial whether human tissues are capable of expressing this protein. Therefore, a polyclonal antibody (8196) was raised against type II NOS from induced RAW 264.7 macrophages and used to investigate the expression of this enzyme in human lung tissue. Anti-type II NOS antibody did not cross-react with either neuronal (type I) or endothelial (type III) constitutive NOS, whereas a 130-kDa protein was detected in cytosol from induced macrophages or liver removed from lipopolysaccharide (25 mg/kg)-treated rats. Cells or tissues that lacked NOS activity did not express immunoreactive proteins. Similarly, in grossly normal human lung tissue, no immunoreactivity was detected with the anti-type II NOS antibody. In contrast, strong immunoreactivity was detected in alveolar macrophages present in lung tissue from a patient with bronchiectasis and acute bronchopneumonia. These data demonstrate that human alveolar macrophages are able to express type II NOS and support a role for this enzyme in pulmonary inflammatory pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517641     DOI: 10.1152/ajplung.1994.266.6.L722

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  The selenium analog of the chemopreventive compound S,S'-(1,4-phenylenebis[1,2-ethanediyl])bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer.

Authors:  Arunangshu Das; James Bortner; Dhimant Desai; Shantu Amin; Karam El-Bayoumy
Journal:  Chem Biol Interact       Date:  2009-03-20       Impact factor: 5.192

Review 2.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses.

Authors:  S C Watkins; W Macaulay; D Turner; R Kang; H E Rubash; C H Evans
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

Review 4.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

5.  Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.

Authors:  F H Guo; H R De Raeve; T W Rice; D J Stuehr; F B Thunnissen; S C Erzurum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

6.  Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.

Authors:  Ian C Davis; Allan J Zajac; Kurt B Nolte; Jason Botten; Brian Hjelle; Sadis Matalon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 7.  Nitric oxide synthase isozymes antibodies.

Authors:  J S Pollock; U Förstermann; W R Tracey; M Nakane
Journal:  Histochem J       Date:  1995-10

Review 8.  Nitric oxide synthase: expression and expressional control of the three isoforms.

Authors:  U Förstermann; H Kleinert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

Review 9.  Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.

Authors:  J B Weinberg
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

10.  Characterization of inducible nitric oxide synthase expression in human airway epithelium.

Authors:  F H Guo; S C Erzurum
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.